Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 3:15:2891-2899.
doi: 10.2147/IDR.S365394. eCollection 2022.

Multidrug-Resistant Tuberculosis Treatment Outcome and Associated Factors at the University of Gondar Comprehensive Specialized Hospital: A Ten-Year Retrospective Study

Teshome Belachew  1 , Seid Yaheya  2 , Nehemia Tilahun  2 , Eshet Gebrie  2 , Rim Seid  2 , Tilahun Nega  3 , Sirak Biset  1
Affiliations

Multidrug-Resistant Tuberculosis Treatment Outcome and Associated Factors at the University of Gondar Comprehensive Specialized Hospital: A Ten-Year Retrospective Study

Teshome Belachew et al. Infect Drug Resist. .

Abstract

Background: Multidrug-resistant tuberculosis (MDR-TB) remains a public health crisis and a health security threat worldwide. Poor public health infrastructure, inefficient infection control and mismanagement of TB treatment are among the reasons for the continuous emergence and spread of drug-resistant TB (DR-TB). The final treatment outcome is the most direct measurement of TB control programs. Therefore, this study sought to determine the proportions and predictors of TB treatment outcomes among MDR/RR-TB treated patients.

Methods: A 10-year, 2011 to 2021, hospital-based retrospective cohort study was conducted at the University of Gondar Comprehensive Specialized Hospital. The records of 408 MDR-TB patients, 389 with treatment outcome and 19 on treatment, were collected using a structured checklist.

Results: A total of 389 patients with a recorded MDR/RR-TB treatment outcome were included. The treatment success rate was 77.12%, with 58.35% cured and 18.76% treatment completed. The proportion of death rate, treatment default loss to follow-up, treatment failure, and unknown treatment outcome was 9.25%, 6.94%, 3.1%, and 3.6%, respectively. Regarding the patient category, the most successful treatment outcome (83.5%) came from patients diagnosed with relapse cases, followed by new cases (81.8%). An unsuccessful treatment outcome was significantly associated with patients aged >44 years (AOR, 3.3, 95% CI = 1.55-6.99).

Conclusion and recommendations: This study indicated that nearly 23% of MDR/RR-TB patients had unsuccessful treatment outcomes and being older was significantly correlated with these outcomes. For better outcomes, it is recommended to strengthen combined treatment adherence interventions and evaluate treatment regimens and administration options. A prospective cohort study may be required to investigate the full range of potential causes of unfavorable outcomes.

Keywords: Ethiopia; multidrug-resistant tuberculosis; rifampicin resistance; tuberculosis treatment outcome.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests in this work.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Furin J, Cox H, Pai M. Tuberculosis. Lancet. 2019;393(10181):1642–1656. doi:10.1016/S0140-6736(19)30308-3 - DOI - PubMed
    1. Zaman K. Tuberculosis: a global health problem. J Heal Popul Nutr. 2010;28(2):111. - PMC - PubMed
    1. Friedman LN, Dedicoat M, Davies PD. Clinical Tuberculosis. 6th ed. Vol. 53; 2020.
    1. Allué-Guardia A, García JI, Torrelles JB. Evolution of drug-resistant mycobacterium tuberculosis strains and their adaptation to the human lung environment. Front Microbiol. 2021;12. doi:10.3389/fmicb.2021.612675 - DOI - PMC - PubMed
    1. World Health Organization. Global tuberculosis report 2020 [Internet]. World Health Organization; 2020. [cited February 17, 2022]. Available from: https://www.who.int/publications/i/item/9789240013131. Accessed May 27, 2022.

LinkOut - more resources